| Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device. |
| |
| Trade Name | ARCHITECT AUSAB, ARCHITECT I1000 SYSTEM |
| Classification Name | test, hepatitis b (b core, be antigen, be antibody, b core igm) |
| Applicant | ABBOTT LABORATORIES INC |
| PMA Number | P050051 |
| Supplement Number | S004 |
| Date Received | 02/12/2009 |
| Decision Date | 07/23/2009 |
| Product Code | |
| Advisory Committee |
Microbiology |
| Supplement Type | normal 180 day track |
| Expedited Review Granted? | No |
| Combination Product |
No
|
Approval Order Statement Approval to extend the application of the architect ausab assay, currently approved for use on the abbott architect i2000/ i 2000sr, onto a new architect i system family member, the architect i 1000sr. Architect ausab reagent kit on architect i 1000sr: the architect ausab assay is a chemiluminescent microparticle immunoassay (cmia) for the quantitative determination of antibody to hepatitis b surface antigen (anti-hbs) in human adult and pediatric serum and plasma (dipotassium edta, lithium heparin, and sodium heparin) and neonatal serum. It is intended for quantitative measurement of antibody response following hepatitis b virus (hbv) vaccination, determination of hbv immune status, and for the laboratory diagnosis of hbv disease associated with hbv infection when used in conjunction with other laboratory results and clinical information. Architect ausab calibrators on architect i 1000sr: the architect ausab calibrators are used to calibrate the architect i system when the system is used for the quantitative determination of antibody to hepatitis b surface antigen (anti-hbs) using the architect ausab reagent kit. The performance of the architect ausab calibrators has not been established with any other anti-hbs assay. Architect ausab controls on architect i 1000sr: the architect ausab controls are used for monitoring the performance of the architect i system when used for the quantitative determination of antibody to hepatitis b surface antigen (anti-hbs) using the architect ausab reagent kit. The performance of the architect ausab controls has not been established with any other anti-hbs assay. |
|
|